Teleflex, Inc. (TFX)
150.87
-1.28
(-0.84%)
USD |
NYSE |
Nov 06, 16:00
150.92
+0.05
(+0.03%)
After-Hours: 20:00
Teleflex Research and Development Expense (Quarterly) : 42.98M for Sept. 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 42.98M |
| June 30, 2026 | 45.12M |
| March 31, 2026 | 44.39M |
| December 31, 2025 | 48.74M |
| September 30, 2025 | 44.26M |
| June 30, 2025 | 26.49M |
| March 31, 2025 | 25.30M |
| December 31, 2024 | 29.20M |
| September 30, 2024 | 38.73M |
| June 30, 2024 | 41.09M |
| March 31, 2024 | 37.30M |
| December 31, 2023 | 35.86M |
| September 30, 2023 | 37.58M |
| June 30, 2023 | 39.45M |
| March 31, 2023 | 41.47M |
| December 31, 2022 | 42.76M |
| September 30, 2022 | 37.77M |
| June 30, 2022 | 36.93M |
| March 31, 2022 | 36.36M |
| December 31, 2021 | 35.80M |
| September 30, 2021 | 31.82M |
| June 30, 2021 | 33.28M |
| March 31, 2021 | 29.95M |
| December 31, 2020 | 33.77M |
| September 30, 2020 | 29.22M |
| Date | Value |
|---|---|
| June 30, 2020 | 29.36M |
| March 31, 2020 | 27.40M |
| December 31, 2019 | 31.13M |
| September 30, 2019 | 27.98M |
| June 30, 2019 | 27.60M |
| March 31, 2019 | 27.15M |
| December 31, 2018 | 27.80M |
| September 30, 2018 | 26.36M |
| June 30, 2018 | 26.02M |
| March 31, 2018 | 26.03M |
| December 31, 2017 | 25.47M |
| September 30, 2017 | 21.19M |
| June 30, 2017 | 20.28M |
| March 31, 2017 | 17.83M |
| December 31, 2016 | 15.69M |
| September 30, 2016 | 15.07M |
| June 30, 2016 | 15.47M |
| March 31, 2016 | 12.35M |
| December 31, 2015 | 13.22M |
| September 30, 2015 | 12.57M |
| June 30, 2015 | 13.44M |
| March 31, 2015 | 12.88M |
| December 31, 2014 | 17.24M |
| September 30, 2014 | 14.87M |
| June 30, 2014 | 14.87M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Globus Medical, Inc. | 34.53M |
| Penumbra, Inc. | 20.08M |
| Abbott Laboratories | 920.00M |
| Becton, Dickinson & Co. | 246.00M |
| Boston Scientific Corp. | 520.00M |